BioSpace News Archive

Biotech Bay

Marrone Bio Innovations Announces New $23 Million Accounts-Receivable and Inventory-Backed Credit FacilitiesNew Credit Facilities to Address Working Capital Required to Support Growing Sales

Marrone Bio (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced a $13.0 million expansion of its existing accounts-receivable credit facility which now totals $20.0 million, as well as the addition of a $3.0 million inventory-backed credit facility to support the Company as it continues to expand its customer base.

January 9, 2020
·
4 min read
Deals

ChemoCentryx Announces Credit Facility of Up to $100 Million with Hercules CapitalNon-dilutive funding vehicle strengthens balance sheet for registration filing of avacopan in ANCA vasculitis and anticipated approval and commercial launch

ChemoCentryx, Inc., announced that the Company has secured a credit facility of up to $100 million provided by Hercules Capital, Inc., a leader in customized financing for companies in life sciences and technology-related markets.

January 9, 2020
·
6 min read
Deals

ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd.

ANI Pharmaceuticals, Inc. (“ANI”) (Nasdaq: ANIP) today announced the acquisition of the U.S. portfolio of 23 generic products from Amerigen Pharmaceuticals, Ltd. for $52.5M in cash at close and up to $25M in contingent profit share payments over the next four years.

January 9, 2020
·
3 min read
Biotech Bay

Gilead Sciences Licenses Portfolio of HIV Antibodies From The Rockefeller University

Gilead Sciences, Inc. announced that the company has licensed The Rockefeller University’s portfolio of broadly neutralizing antibodies against HIV, including the two clinical-stage agents 3BNC117 and 10-1074.

January 9, 2020
·
4 min read
Business

Neogen, Gencove partner to advance animal genomics

Gencove’s flagship product is its low-pass whole genome sequencing platform, which is a technology that has the potential to more accurately assess the genetic potential of an animal earlier in its life.

January 9, 2020
·
2 min read
Pharm Country

Royal Biologics Launches MAGNUS, a DMSO-free Viable Cellular Bone AllograftExpands its portfolio of orthobiologic solutions for fusion in orthopedics, ideal for bone graft-based procedures

Royal Biologics, an orthobiologics company specializing in the research and advancement of regenerative cellular therapy and novel orthobiologic solutions, has announced the launch of MAGNUS, a DMSO-free viable cellular bone allograft.

January 9, 2020
·
2 min read
Business

Editas Medicine Strengthens Executive Leadership Team to Support Long-term Growth

Manufacturing veteran Harry Gill joins in newly created role of Senior Vice President, Operations

January 9, 2020
·
5 min read
Business

Evolus Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Revenue

Evolus, Inc. announced its preliminary unaudited revenues for the fourth quarter and full year ended December 31, 2019 and cash position at December 31, 2019.

January 9, 2020
·
5 min read
Business

International Myeloma Foundation Partners with Medscape Oncology to Create Professional Education Series on Continuous Treatment in Multiple Myeloma

The International Myeloma Foundation announces the launch of a new program created in partnership with Medscape Oncology that offers healthcare professionals an opportunity to earn continuing medical education (CME) credit

January 9, 2020
·
3 min read
Drug Development

Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer

Zai Lab Limited and Novocure announced that the first patient has been enrolled in a phase 2 pilot clinical trial evaluating the safety and efficacy of Tumor Treating Fields in combination with chemotherapy as a first-line treatment in patients with gastric adenocarcinoma.

January 9, 2020
·
8 min read